A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 153 participants.
Also called NCT02681952
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 153 participants
- Registry
-
NCT02681952
-
- Other papers using this trial's data
- Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02681952. Randomized; no masking; primary purpose other. Start 2015-12 (registry gives no type); primary completion 2016-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure
- Condition
- Chronic Renal Failure
- Intervention (Drug)
- Renamezin capsule
- Intervention (Drug)
- Kremezin granule
- Lead sponsor
- Daewon Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct02681952- Content hash
0cd3a2432b63f7d63c0e69e5ac74dde2f14a26ff63c17fce78025d61e9f9b9f6